These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10025070)

  • 1. [Reproducibility of the effectiveness of defibrillation for terminating induced ventricular fibrillation using intraoperatively measured defibrillation threshold energy in patients with implanted cardioverter-defibrillator].
    Jung J; Neuzner J; Himmrich E; Vester E; Michel U; Fries R; Pitschner H; Liebrich A; Ganschow U; Heisel A
    Z Kardiol; 1998 Dec; 87(12):971-7. PubMed ID: 10025070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)].
    Himmrich E; Liebrich A; Michel U; Neuzner J; Pitschner H; Heisel A; Vester E; Ganschov U; Jung J
    Z Kardiol; 1999 Feb; 88(2):103-12. PubMed ID: 10209831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety margins: lessons from the Low Energy Endotak Trial (LEET).
    Neuzner J
    Am J Cardiol; 1996 Sep; 78(5A):26-32. PubMed ID: 8820833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter Low-Energy Endotak Trial.
    Neuzner J; Liebrich A; Jung J; Himmrich E; Pitschner HF; Winter J; Vester EG; Michel U; Nisam S; Heisel A
    Am J Cardiol; 1999 Mar; 83(5B):34D-39D. PubMed ID: 10089837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm.
    Birgersdotter-Green U; Undesser K; Fujimura O; Feld GK; Kass RM; Mandel WJ; Peter CT; Chen PS
    J Interv Card Electrophysiol; 1999 Jul; 3(2):155-61. PubMed ID: 10387143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and efficacy of intraoperative defibrillation threshold measured by defibrillation safety margin in 52 patients with implantable cardioverter defibrillator].
    Zhang Y; Yuan KD; Tang BP; Ma YT; Zhang YY; Wang J; Li JX; Zhang JH; Xu GJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):975-8. PubMed ID: 21215224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
    Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C
    Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implantable cardioverter/defibrillator: long-term stability of the defibrillation threshold with a unipolar electrode configuration (active-can")].
    Knuefermann P; Wolpert C; Spehl S; Korte T; Manz M; Lüderitz B; Jung W
    Z Kardiol; 2000 Sep; 89(9):774-80. PubMed ID: 11077687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing.
    Green UB; Garg A; Al-Kandari F; Ungab G; Tone L; Feld GK
    J Interv Card Electrophysiol; 2003 Feb; 8(1):71-5. PubMed ID: 12652181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term performance of a tripolar down-sized single lead for implantable cardioverter defibrillator treatment: a randomized prospective European multicenter study. European Endotak DSP Investigator Group.
    Sandstedt B; Kennergren C; Schaumann A; Herse B; Neuzner J
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2087-94. PubMed ID: 9826861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II.
    Gradaus R; Block M; Seidl K; Brunn J; Isgro F; Hammel D; Hauer B; Breithardt G; Bocker D
    J Cardiovasc Electrophysiol; 2001 Aug; 12(8):921-7. PubMed ID: 11513444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized comparison in humans of biphasic waveform 60-microF and 120-microF capacitance pulses using a unipolar defibrillation system.
    Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Mehra R; DeGroot P; Raitt MH; Jones GK; Johnson G
    Circulation; 1995 Jan; 91(1):91-5. PubMed ID: 7805224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator.
    Rudic B; Tülümen E; Fastenrath F; Akin I; Borggrefe M; Kuschyk J
    Heart Rhythm; 2020 Mar; 17(3):455-459. PubMed ID: 31669771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators.
    Gold MR; Breiter D; Leman R; Rashba EJ; Shorofsky SR; Hahn SJ
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):483-6. PubMed ID: 12687873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
    Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
    Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS).
    Gold MR; Higgins S; Klein R; Gilliam FR; Kopelman H; Hessen S; Payne J; Strickberger SA; Breiter D; Hahn S
    Circulation; 2002 Apr; 105(17):2043-8. PubMed ID: 11980683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.